it is very quite here at Baxter in the Bioscience divisions - including the ivig and hemophilia business units. Is this the calm before the storm. Will the hemophilia organization decrease from 30 to 15? Heck our product is 6 + years old and is still over priced. No of us TBM's are making any money in commissions. Our counterparts are not hitting their goals. I am not sure about a layoff coming but wanted to put it out there and see if anyone has the or some information. Like I said it is very very calm right now.